Jennifer Cross

Jennifer Cross has a diverse work experience in the pharmaceutical industry. Jennifer is currently the Vice President of Experimental Medicine at Aurinia Pharmaceuticals Inc., a role they started in March 2022. Prior to this, they were the Senior Director of Experimental Medicine at the same company from April 2019 to March 2022.

Before joining Aurinia Pharmaceuticals Inc., Jennifer worked at Novateur Ventures Inc. as a Preclinical and Drug Development professional from February 2019 to March 2022.

From December 2014 to December 2018, Jennifer was a Sr. Manager of Translational Biology at Aquinox Pharmaceuticals, Inc. Jennifer also had experience as a Research Scientist at Tekmira Pharmaceutical Corporation from April 2013 to December 2014.

Prior to that, they were a Research Associate at James Hogg Research Institute from September 2012 to April 2013. Jennifer began their career as a Research Scientist at Aquinox Pharmaceuticals Inc. in 2009 and worked there until 2012.

Jennifer's educational background includes being a Grad student/post-doc at The University of British Columbia from 2002 to 2009.

Jennifer Cross completed their education at The University of British Columbia from 2002 to 2008. Jennifer pursued a Doctor of Philosophy (Ph.D.) degree in the field of Immunology during this period.